Leaderboards/T Cell Engineering

T Cell Engineering

Last updated May 19, 2026

Rising Stars

New and hot

Rising Stars Researchers

1
Theresa Hunter
Unknown
582 cit.
2
Dongping Xue
Zhengzhou University
284 cit.
3
Longwei Liu
University of Southern California
147 cit.
4
Nishith R. Reddy
University of California, San Francisco
144 cit.
5
Nicholas A. Kalogriopoulos
Stanford University
129 cit.
6
Taha Rakhshandehroo
Dana-Farber Cancer Institute
117 cit.
7
Ligang Yuan
State Key Laboratory of Luminescent Materials and Devices
108 cit.
8
Jutaek Nam
Chonnam National University
103 cit.
9
Jessie M. Barra
University of Florida
102 cit.
10
Julian Geilenkeuser
Helmholtz Zentrum München
99 cit.

Rising Stars Papers

1
In vivo CAR T cell generation to treat cancer and autoimmune disease
Science|2025
193 cit.
2
Spin occupancy regulation of the Pt d-orbital for a robust low-Pt catalyst towards oxygen reduction
Nature Communications|2024
141 cit.
3
Engineering sonogenetic EchoBack-CAR T cells
Cell|2025
48 cit.
4
Engineering synthetic suppressor T cells that execute locally targeted immunoprotective programs
Science|2024
47 cit.
5
Synthetic GPCRs for programmable sensing and control of cell behaviour
Nature|2024
42 cit.
6
A CAR enhancer increases the activity and persistence of CAR T cells
Nature Biotechnology|2024
38 cit.
7
Bottom Contact Engineering for Ambient Fabrication of >25% Durable Perovskite Solar Cells
Advanced Materials|2024
53 cit.
8
Engineered polysaccharides for controlling innate and adaptive immune responses
Nature Reviews Bioengineering|2024
40 cit.
9
Combinatorial genetic engineering strategy for immune protection of stem cell-derived beta cells by chimeric antigen receptor regulatory T cells
Cell Reports|2024
33 cit.
10
Engineered nucleocytosolic vehicles for loading of programmable editors
Cell|2025
32 cit.

Rising Stars Reagents

Coming soon

Emerging Leaders

Gaining momentum

Emerging Leaders Researchers

1
Jennifer A. Doudna
QB3
504 cit.
2
Li Tang
École Polytechnique Fédérale de Lausanne
381 cit.
3
Paul G. Thomas
St. Jude Children's Research Hospital
368 cit.
4
Phillip K. Darcy
The University of Melbourne
309 cit.
5
David R. Liu
Broad Institute
266 cit.
6
Martin Vaeth
University of Würzburg
171 cit.
7
Lei S. Qi
Chan Zuckerberg Initiative (United States)
162 cit.
8
Robert A. Montgomery
NYU Langone Health
145 cit.
9
Yonghui Zhang
King Center
123 cit.
10
Dali Li
East China Normal University
112 cit.

Emerging Leaders Papers

1
IL-10-expressing CAR T cells resist dysfunction and mediate durable clearance of solid tumors and metastases
Nature Biotechnology|2024
254 cit.
2
Principles and therapeutic applications of adaptive immunity
Cell|2024
245 cit.
3
In vivo human T cell engineering with enveloped delivery vehicles
Nature Biotechnology|2024
214 cit.
4
FOXO1 enhances CAR T cell stemness, metabolic fitness and efficacy
Nature|2024
206 cit.
5
Phage-assisted evolution and protein engineering yield compact, efficient prime editors
Cell|2023
266 cit.
6
Mitigation of chromosome loss in clinical CRISPR-Cas9-engineered T cells
Cell|2023
183 cit.
7
Mitochondrial dysfunction promotes the transition of precursor to terminally exhausted T cells through HIF-1α-mediated glycolytic reprogramming
Nature Communications|2023
257 cit.
8
A versatile CRISPR-Cas13d platform for multiplexed transcriptomic regulation and metabolic engineering in primary human T cells
Cell|2024
108 cit.
9
Immune response after pig-to-human kidney xenotransplantation: a multimodal phenotyping study
The Lancet|2023
145 cit.
10
Phosphoantigens glue butyrophilin 3A1 and 2A1 to activate Vγ9Vδ2 T cells
Nature|2023
123 cit.

Emerging Leaders Reagents

Coming soon

All-Time Leaders

The canon

All-Time Leaders Researchers

1
David R. Liu
Howard Hughes Medical Institute
12.4k cit.
2
Matthias Mann
University of Southern Denmark
5.6k cit.
3
Alexander Marson
University of California, San Francisco
5.3k cit.
4
R. A. Schilperoort
Leiden University
5.3k cit.
5
Michel Sadelain
Memorial Sloan Kettering Cancer Center
5.1k cit.
6
Wendell A. Lim
Howard Hughes Medical Institute
4.2k cit.
7
Saar Gill
University of Pennsylvania
4.2k cit.
8
Akihiko Kondo
Kobe University
4.1k cit.
9
Carl H. June
Cancer Research Institute of the Slovak Academy of Sciences
4.1k cit.
10
William B. Kannel
American Heart Association
3.7k cit.

All-Time Leaders Papers

1
Programmable base editing of A•T to G•C in genomic DNA without DNA cleavage
Nature|2017
4.2k cit.
2
Stable Isotope Labeling by Amino Acids in Cell Culture, SILAC, as a Simple and Accurate Approach to Expression Proteomics
Molecular & Cellular Proteomics|2002
5.6k cit.
3
A binary plant vector strategy based on separation of vir- and T-region of the Agrobacterium tumefaciens Ti-plasmid
Nature|1983
1.8k cit.
4
Human chimeric antigen receptor macrophages for cancer immunotherapy
Nature Biotechnology|2020
1.4k cit.
5
Targeted nucleotide editing using hybrid prokaryotic and vertebrate adaptive immune systems
Science|2016
1.4k cit.
6
An updated coronary risk profile. A statement for health professionals.
Circulation|1991
1.9k cit.
7
Virus-specific T cells engineered to coexpress tumor-specific receptors: persistence and antitumor activity in individuals with neuroblastoma
Nature Medicine|2008
1.2k cit.
8
IMGT(R), the international ImMunoGeneTics information system(R)
Nucleic Acids Research|2008
1.1k cit.
9
Control of large, established tumor xenografts with genetically retargeted human T cells containing CD28 and CD137 domains
Proceedings of the National Academy of Sciences|2009
886 cit.
10
IMGT, the international ImMunoGeneTics database
Nucleic Acids Research|2000
876 cit.

All-Time Leaders Reagents

Coming soon

Indexing T Cell Engineering Reagents

Citation data for reagents in this field is currently compiling.